Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-01-20 @ 8:16 PM
Study NCT ID:
NCT01091103
Status:
COMPLETED
Last Update Posted:
2018-10-23
First Post:
2010-03-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Progressive Castration-resistant Prostate Cancer | View |
Keywords: